Abstract
Introduction
Diabetes continues to be a serious health condition with the capacity to damage several tissues and organs including nerves and blood vessels. Complications resulting from these factors can give rise to debilitating peripheral neuropathy, approximately 50% of patients develop this condition during the progression of the disease [1, 2] . The gradual deterioration of nerve function is characterized by slowing of nerve conduction velocity, abnormal thermal [3] . Diabetic peripheral neuropathy (DPN) is a major cause of morbidity that can lead to excessive foot ulceration and subsequent limb amputation [4] . The vascular mechanism of destruction of neuronal and Schwann cells (SCs) [5] . The pathogenesis of DPN is considered to the vasa nervorum, the microvessels that supply blood to neural tissue [6, 7] . High glucose role in DPN [8] . Although glycemic control can prevent the progression of DPN, whether it has the capability of reversing the condition has not been established. Cell transplantation has proven to be a useful therapy for treating peripheral nerve injuries [9] . SCs are a type of glia cell that are involved in the maintenance and protection of along axons, nerve and axon development, and axonal regeneration. SCs also promote hyperglycemic conditions reduce the survival ratio of SCs and consequently suppress their function in promoting nerve growth. Transplantation of SCs into bioengineered conduits can improve regeneration by bridging nerve grafts [10, 11] . Previous studies have shown cells in vitro [12] . Dai et al SCs, ASCs, dental pulp stem cells (DPSCs), and the combination of SCs with ASCs or DPSCs seeded on nerve conduits to repair rat sciatic nerves [13] . A combination of SCs and ASCs or gait, nerve conduction velocity, and histological analysis. The regenerative capacity of nerve grafts could possibly be further improved by genetically modifying SCs [14, 15] .
Recent studies support a defensive role of Nrf2 in neurons under conditions of oxidative sciatic nerve of diabetic animals [17] . and without DPN. We also studied the effects of high glucose on the expression and level of without the overexpression of Nrf2. Then we determined the effect of Nrf2 overexpression in in a diabetic rat model with peripheral nerve injury.
Materials and Methods

Ethics Statement
All animal/human experiments were performed with the approval of the animal/human ethics committee of the Shanghai Changzheng Hospital, China. Experiments were conducted by following established guidelines for animal/human care and were approved by the animal/human ethics committee of the Shanghai Changzheng Hospital, China. Reagents bovine serum were from Nego (Shanghai, China). Cell lysis buffer (10×) was from Cell Signaling Technology
Aldrich. All other chemicals and reagents were of analytical grade.
Subjects
A total of 104 subjects were recruited from Shanghai Changzheng Hospital from April 2014 to June 2015. The normal control subjects (NC, n = 25) had no family history of diabetes or other chronic diseases, normal glucose tolerance, were free of any major organ disease, and had a stable body weight n = 79) was performed according for a minimum of 6 months were diagnosed with diabetes. The inclusion criteria for the patients studied retinopathy, nephropathy or microalbuminuria and any other conditions related to neuropathy. The study was approved by the ethical committee at Shanghai Changzheng Hospital, China. A written, signed and informed consent was obtained from each participant. Diabetic patients were divided into two groups history of hyperglycemia, evidence of neuropathy or renal disease. A detailed questionnaire was completed for each of the 104 participants. The obtained information and diastolic blood pressure.
Biochemical Assessments
examination. Ten milliliters of blood were collected into a tube containing ethylenediaminetetraacetic acid, centrifuged under refrigeration at 3000 rpm for 10 min for the separation of plasma. The plasma was used
Schwann Cell Culture
bovine serum in an incubator. The culture medium was refreshed every 2 days. Cells from the 2nd to 5th passages were used in this study. 
Induction of Diabetes
Shanghai SLAC Laboratory Animal Co., Ltd. (China) and housed in individual microisolators or cages with diabetic group. Rats were housed in a room maintained under controlled temperature and humidity on a 12
Surgical and Transplantation Procedure 6 gastrocnemius muscle. Each group contained six rats.
Lentiviral Vector Construction and Infection
harvested and used for the infection of SCs.
Quantitative Real-Time PCR
. 
Detection of Intracellular ROS
Statistical Analysis
All data are presented as the mean ± SD. Differences between treatment groups were analyzed using
Results
Neuropathy
and triglycerides were patients compared with DN patients (P were also higher in DPN patients compared with DN patients (P factors measured, including HbA1c, fasting plasma and TLR4, were higher in DN and DPN patients compared to patients in the control group (Table 1) .
in patients with high plasma glucose levels and these levels increase with the progression of the disease and presence of peripheral neuropathy.
Factor Levels Through
Pathway in Schwann Cells
When SCs are cultured with NG or HG with or SCs cultured with HG compared with NG (P < (P P together, these results indicate that 2a). Western blot analysis was used to in HG than in NG (P these levels were reduced when cells 242 with levels of TLR4 (P P P to HG (P 
Schwann
respectively. The levels of Nrf2 protein and RNA were upregulated after transfection with a Nrf2 expression vector (P conditions decreased with overexpression of Nrf2 (P P P P Protein levels of TLR4 returned to those found in NG conditions (P P P P P P P were reduced in HG (P P P P P P 
Transplantation of Schwann Cells Nerves Through the Increased Vascularity of the Vasa Nervorum
Transplantation with SCs overexpressing Nrf2 restored crushed sciatic nerves through increasing the vascularity of sciatic vasa nervorum in DN rats. Table 2 compares the quantity Transplantation with SCs and SCs overexpressing Nrf2 increased both vascularity and nerve density in crushed sciatic nerves compared to the control with levels approaching group for both SCs (P P rats and the normal group, therefore, only the control group data is shown. The survival of Nrf2 restored SNCV in nerve injury DPN rats and increased vascularity of the vasa nervorum.
Discussion
As Nrf2 has been implicated in promoting remyelination after peripheral nerve injury studied the effect of hyperglycemia in the presence and absence of Nrf2 on SC survival at peripheral nerve injury was assessed in an animal model through targeted muscular injection. The measurements of the patients in our study were within that level but were still not [23] . Schratzberger et al. partly reversed the development of reduced nerve conduction in vitro [24] . However, in clinical trials, no great improvement was reported in nerve conduction velocities and despite the initial promise of gene therapy, there is still currently no treatment natural medicines have been found to relieve the symptoms of DPN through antioxidant properties and by inhibiting the apoptotic nature of SCs in hyperglycemic conditions [28, 29] . been used to treat diabetes and paralysis, is thought to inhibit the apoptotic nature of SCs interactions between TLR4 and its adaptor molecules [30] . We cultured SCs in the presence conditions but the addition of a TLR4 inhibitor along with the subsequent inhibition of in DPN, it has been proposed that the activation of an antioxidant response in dorsal root SCs in hyperglycemic conditions, we overexpressed Nrf2 in SCs. The Nrf2 transcription factor binds to antioxidant response elements to elicit the response of antioxidative and electrophilic insults [36] . Nrf2 is thought to promote remyelination after peripheral nerve 
